GLP-1 Medications and Skin: What Beauty Professionals Must Know, Especially When Treating Skin of Color

Darker skin responds to inflammation differently than lighter skin tones, and GLP-1s can heighten the risk of inflammation.
Darker skin responds to inflammation differently than lighter skin tones, and GLP-1s can heighten the risk of inflammation.
Image by Studio Romantic / Adobe Stock

GLP-1 medications have quickly moved from medical offices into everyday conversation. Originally prescribed for diabetes management and now widely used for weight loss, these medications are changing not only bodies, but skin. 

Accelerated volume loss, particularly in the face (aka Ozempic Face)

Increased dehydration due to reduced nutritional intake 

Compromised barrier function, making skin more reactive 

Slower cellular recovery, especially after exfoliation or advanced treatments 

Aggressive chemical peels 

Multiple exfoliation layers in a single service 

High-heat modalities that increase inflammation 

Strong acid protocols without barrier assessment 

“Corrective” treatments that prioritize speed over skin health 

Updating consultation forms to include GLP-1 and weight-loss medications 

Prioritizing barrier repair, hydration and inflammation control 

Slowing treatment timelines and spacing advanced services further apart

Educating clients on realistic skin expectations during GLP-1 use 

Documenting skin responses carefully and adjusting protocols accordingly 

Barrier-supportive facials focused on lipid restoration 

Enzyme-based exfoliation instead of aggressive acids 

Hydration-forward treatments that reduce transepidermal water loss 

Calming, anti-inflammatory protocols 

Long-term skin health plans rather than “quick fix” correction 

This article is only available to registered users.

Log In to View the Full Article

More in Health